Lipha
Records under this name other than patents Lipha holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,034,021 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses Formerly held Term ended Term ended Oct 31, 2021 · From the USPTO record | Term ended | Term ended Oct 31, 2021 | From the USPTO record |
| US 7,767,676 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses Formerly held Term ended Term ended Oct 25, 2021 · From the USPTO record | Term ended | Term ended Oct 25, 2021 | From the USPTO record |
| US 7,452,883 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses Formerly held Term ended Ended no later than Jan 25, 2021 · From the USPTO record | Term ended | Ended no later than Jan 25, 2021 | From the USPTO record |
| US 6,512,009 | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator Formerly held Term ended Term ended Jan 12, 2021 · From the USPTO record | Term ended | Term ended Jan 12, 2021 | From the USPTO record |
| US 6,265,437 | Aminoalkanesulphonic acid derivatives, their preparation and their use as medicaments Formerly held Term ended Term ended Oct 12, 2020 · From the USPTO record | Term ended | Term ended Oct 12, 2020 | From the USPTO record |
| US 7,159,012 | Computational data processing system and computational process implemented by means of such a system Lapsed on the fee record Ended Jan 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2015 | From the USPTO record |
| US 6,303,146 | Solid oral dosage form comprising a combination of metformin and glibenclamide Formerly held Surrendered on reissue Surrendered on reissue Oct 19, 2004 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Oct 19, 2004 | From the USPTO record |
| US 4,355,043 | Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane Term ended Term ended no later than Oct 19, 2002 · Low confidence | Term ended | Term ended no later than Oct 19, 2002 | Low confidence |
| US 4,652,583 | Use of naftidrofuryl to regenerate nerve fibers Term ended Term ended no later than Mar 24, 2007 · Low confidence | Term ended | Term ended no later than Mar 24, 2007 | Low confidence |
| US 4,746,679 | Novel pharmaceutical compositions improving the psychomotor performances and a process for producing the same Term ended Term ended no later than May 24, 2008 · Low confidence | Term ended | Term ended no later than May 24, 2008 | Low confidence |